Last reviewed · How we verify
NCT04467333: PHLHR
Giessen Pulmonary Hypertension in Lung Cancer Registry
trial testing All lung cancer patients. in Pulmonary Hypertension Due to Lung Diseases and Hypoxia in 500 participants. Currently enrolling.
29 January 2026
Quick facts
| Lead sponsor | University of Giessen |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 29 June 2020 |
| Primary completion | 29 January 2026 |
| Estimated completion | 29 January 2040 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- All lung cancer patients.
Conditions studied
- Pulmonary Hypertension Due to Lung Diseases and Hypoxia — all drugs for Pulmonary Hypertension Due to Lung Diseases and Hypoxia →
Sponsor
University of Giessen
Who can join
18 and older, any sex, with Pulmonary Hypertension Due to Lung Diseases and Hypoxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Echocardiographic Measure of Right Ventricular-Pulmonary Arterial Coupling Predicts Survival in Lung Cancer.
Rako ZA, Cekay M, Yogeswaran A, Yildiz S, et al · · 2025 · cited 1× · PMID 40042816 · DOI 10.1513/annalsats.202409-949oc -
Reply to Zheng <i>et al</i>.
Eul B, Cekay M, Tello K, Wilhelm J, et al · · 2021 · PMID 34473933 · DOI 10.1164/rccm.202106-1411le
Verify or expand the search:
- PubMed search for NCT04467333
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Currently open trials in the same condition.
- NCT06512935 — Ventilator Pressure and Optimization of Compliance and Hemodynamics · NA · recruiting
- NCT06388421 — DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease · recruiting
- NCT04808596 — Pulmonary Hypertension Biorepository and Registry · recruiting
Other University of Giessen trials
Trials by the same sponsor.
- NCT07505511 — Visualization of the Effects of Guideline-directed Medical Therapy (GDMT) on Improving Adherence and Quality of Life in · EARLY_PHASE1 · not yet recruiting
- NCT07488468 — Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures · recruiting
- NCT06966739 — Multispectral Optoacustic Imaging in Patients With Myositis · completed
- NCT06381427 — Perioperative Interdisciplinary, Intersectoral Process Optimization in Heart Failure · NA · recruiting
- NCT06291714 — Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04467333 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Giessen
- Last refreshed: 1 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04467333.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing